The Pros and Cons of a Single 'Euro-Price' for Drugs
Pharmacoeconomics 1998 March; 13(3): 271-276
Showing items related by title, author, creator and subject.
Genetic screening, health care and the insurance industry. Should genetic information be made available to insurers? Ossa, Diego F.; Towse, Adrian (2004-06)
Danzon, Patricia; Towse, Adrian (2002-01)
The genomic revolution: is the real risk under-investment rather than bankrupt health care systems? Danzon, Patricia; Towse, Adrian (2000-10)